Canabo Medical (CMM.V) is poised to capitalize on the newest growth segment in the medical marijuana sector – big data. Chris Parry speaks with Advisory Board member, James Megann, and Executive Chairman, Dr. Neil Smith, about the company, it’s direction and how it will impact shareholder value. Have a look!
Watch live video from EquityDotGuru on www.twitch.tv
FULL DISCLOSURE: Canabo Medical is an EQUITY.GURU client.
These guys need to work on making their current shops profitable, all of their expansion is meaningless if they can’t figure out how to monetize their core business model. Next few quarters need to bring good news or this stock will drop even faster than it has the past month. The fact that Aphria sold off 2.5m shares of this company certainly does not inspire confidence.